ABCAM Plc Annual Financial Report (5176T)

TIDMABC

RNS Number : 5176T

ABCAM Plc

06 October 2014

 
 For immediate release   6 October 2014 
 

ABCAM PLC

("Abcam" or "the Company")

Annual Report and Accounts

Abcam plc (AIM: ABC), a global leader in the supply of life science research tools announces that its Annual Report and Accounts for the year ended 30 June 2014 has been posted to shareholders and is being made available at the Company's investor relations website, www.abcamplc.com.

For further information please contact:

 
 Abcam                                     + 44 (0) 1223 696 000 
 Alan Hirzel / Jeff Iliffe 
 Numis Securities - Nominated Adviser 
  and Joint Broker                         + 44 (0) 20 7260 1000 
 Michael Meade - Nominated Adviser 
 James Black - Corporate Broking 
 Peel Hunt LLP - Joint Broker              + 44 (0) 20 7418 8900 
 Clare Terlouw / Jock Maxwell MacDonald 
  - Corporate Broking 
 Brunswick                                 + 44 (0) 20 7404 5959 
 Justine Mcllroy / Robin Wrench / Emma 
  Walsh 
 

Notes for editors:

About Abcam plc

Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices enabling local services, multi-language support sells to over 100 countries. The Company was founded in 1998, and now employs over 740 people. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, please visit www.abcam.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSQKADNCBDKOKK